Moloney-murine sarcoma virus (S+L-strain of M-MSV) has been nonproductively cloned in murine and non-murine host cells (S + L-cells) and the expression of Moloney leukaemia virus (M-MuLV) 30oo0 mol. wt. core protein (p3o) and envelope glycoprotein (gp69/70 were studied by radioimmunoassay. Antigenic determinants of the M-MuLV p3o were associated with the sarcoma virus genome in these non-productively transformed cell clones studied, while the determinants of M-MuLV gp69/71 were not. The absence of envelopeassociated glycoprotein expression in sarcoma virus transformed cells was confirmation of biological studies demonstrating that rescued sarcoma virions acquire envelope-associated properties of host range, neutralization and interference from rescuing helper virus, and further evidence that the M-MuLV gp69/7I sequences have been deleted during the formation of the M-MSV.
INTRODUCTION
Some mammalian type C viruses are known to cause leukaemias, lymphomas and sarcomas (Gross, I97o; Harvey & East, I97I ; Scher et al. I975; Tooze, I973) . These oncogenic type C viruses appear to cause disease by two different mechanisms. The first, exemplified by leukaemias resulting after a long incubation period such as the leukaemia of AKR mice (Lilly et al. I975) , may occur in vivo by increasing, during replication of these viruses, the levels of RNA from potentially oncogenic cells or other integrated virus transforming genes (Peebles et al. I976b) .
The second mechanism by which the mammalian type C viruses cause cancer is by the formation of replication-defective true deletion mutants which have recombined with potentially oncogenic information of cell or virus origin (Peebles et al. I975; Scolnick et aL I975b; Frankel & Fischinger, I976) . These replication-defective transforming viruses, when injected into animals, rapidly cause sarcomas or leukaemias (Harvey, I964; Moloney, t966; Gross, I97O; Theilen et al. T97I; Scher et al. I975) . Characteristically, these viruses are able to enter and transform fibroblasts and other cells but they are defective and unable thereafter to replicate progeny virions without their associated undeleted replicating nontrangforming helper type C viruses (Huebner et al. I966; Peebles et al. I97I) . Certain of these defective-transforming viruses have been cloned in non-productively infected heterologous host cells in order to study their nucleic acid sequences and their remaining helper virus structural protein expression in the absence of the associated helper virus (Bassinet al. I97I b; Aaronson et al. I972; Peebles et al. I973, I975; Aaronson et al. I975; Scolnick et al. 1975 a) . Previous studies have demonstrated that the best studied of these viruses, the S + L-strain of Moloney-murine sarcoma virus (S + L-M-MSV), apparently lacks the information for virus reverse transcriptase but continues to code for an approx. 6oooo mol. wt. protein precursor (p6o) which is cleaved to yield the p3o, pI5 and plz proteins of M-MuLV (Oskarsson et al. I975; Peebles et al. I976a) . The data herein confirm the presence of the p3o determinant in S + L-heterologous host ceils by radioimmunoassay and further indicate that the envelope glycoprotein of approx. 70 ooo mol. wt. (gp69/7 I) does not appear to be linked to or expressed by the S + L-M-MSV genome.
METHODS
Cell lines and culture techniques. The origin and culture methods of 3T3FL normal mouse cells, canine kidney cell line MDCK, mink lung cell line, MV-I-Lu, human AV-3 and L-I32 cells have been described previously (Bassinet al. I97I a; Peebles et al. I973, 1975) .
Virus antigen preparations of normal, S + L-cells and cell culture supematants. Approx. 2x io s normal and S+L-murine and non-murine cells were washed three times with phosphate buffered saline before resuspension in TEN buffer [20 mM-tris-HC1 (pH 7-6), I mM-sodium EDTA, IOO mM-NaC1], centrifuged at 2o00 g for 5 min, recentrifuged after a second wash with TEN buffer, and the cell pellet frozen and stored at -70 °C before assay. Cell culture supernatants were centrifuged at 2000 g for 5 min at 4 °C and clarified again at loooo g for 2o min at 4 °C.
Virus protein purification, antisera and radioimmunoassays. The major structural protein of Rauscher MuLV (R-MuLV p3o) and the virus membrane glycoprotein of Rauscher MuLV (gp69/7I) were purified as previously described (Strand & August, I974) . Rabbit anti-FeLV (Theilen) and goat anti-Rauscher MuLV p3o sera were prepared and characterized as previously described (Strand & August, 1974 )-Quantitative analysis of virus antigens was carried out by competition radioimmunoassay as described by Strand & August 0974). A limiting amount of antiserum sufficient to precipitate approx. 5o% of labelled virus antigen was added and the competitive inhibition of binding of labelled antigen by unlabelled virus protein was measured. 
RESULTS

Derivation of cells transformed by Moloney-murine sarcoma virus
Analysis oa¢S+ L-cells for virus p3o
The concentration of virus p3o protein in the different S + L-and control cells was measured by competition radioimmunoassay. The interspecies assay system using purified Rauscher virus p3o as l~SI-labelled antigen and anti-FeLV serum (data not shown) measured the interspecies determinants of virus p3o protein in S + L-cells but not in uninfected cells. Alone, these assays did not distinguish the several possible sources for this antigen, 
Expression of virus envelope glycoprotein
The possible expression of the interspecies antigenic determinants of virus envelope glycoprotein was studied with an assay system containing Rauscher gp69/7I antigen and anti-feline virus serum (Fig. 2) . It had previously been found that the interspecies reactivity of the Rauscher glycoprotein in this system was limited and would detect only murine and feline virus glycoproteins (Strand & August, I974).
A remarkable finding was that the normal 3T3FL cells expressed a high concentration of the glycoprotein, equivalent to that which normally would be found in productively infected cells (iooo ng/ml). This finding indicates the advantage of studying MSV in heterologous host cells presumably lacking the endogenous viruses seen in mouse cells.
The other normal cells showed an apparent low affinity displacement at high protein concentrations. Such displacement with l~5I-labelled gp69/7I antigen from concentrated cell or tissue extracts is commonly observed, but because of the apparent low affinity reaction, it is not considered to be positive for virus envelope antigenic determinants.
The S+ L-cells of murine origin were all positive for envelope glycoprotein; as these were all 3T3FL cells, this can be attributed to the normal expression of the virion envelope of an endogenous virus (Nomura et al. I976) , not to an MSV-coded gene product. The displacement curves of the remaining S + L-cells of dog, human and mink resembled those of normal cells.
Release of virus proteins by S+ L-dog cells
The release of virus proteins by the S + L-cells, possibly as some type of particle, was studied by analysis of the tissue culture fluid for the presence of p3o antigenic determinants. For example, the endogenous virus genes of the cell could provide the virion envelope and possibly other proteins, whereas the sarcoma virus could code for the p3 o and other small mol. wt. protein present in the 650o0 mol. wt. precursor polypeptide (Oskarsson et al. ~975) . In the case of cells of murine origin, the formation of pseudotype viruses comprised of sarcoma virus genes and proteins of endogenous murine virus is well known (Nomura et al. I976) and earlier reports of the synthesis of defective particles by S + L-cells infected by the Moloney-MSV can now be attributed to the formation of such pseudotypes (Bassin et al. I97Ib) .
In the heterologous assay system (murine 125I-labelled p3o and anti-feline virus serum) no p3o antigenic determinants were detected in supernatant fluids from S + L-and normal human and mink or normal dog cell clones. In contrast, culture fluids from the S + L-dog cells showed a high concentration of protein carrying p3o interspecies antigenic determinants (Fig. 3a) . The murine identity of this protein was demonstrated by use of the homologous competition assay (Rauscher murine virus p3o and anti-Rauscher murine p3o) specific for type and group antigenic determinants of the protein (Strand & August, 1974;  Fig. 3 b) . The lower affinity and reduced concentration of antigenic determinants are expected for a murine virus other than Rauscher virus in this assay system. It thus appears that the dog S + L-cells are releasing protein containing the p3o antigenic determinants. The amount of this protein is comparable to that found in the supernatant fluids of RD-I I4 superinfected MSV producing S + L-dog cells.
These S + L-dog cells were then studied by electron microscopy and 3H-uridine banding in sucrose gradients. There was no detectable virus particle production and certainly not of The S + L-strain of M-MSV has been cloned and recloned in non-murine host cells in the absence of detectable replicating helper viruses. These cells have been examined by radioimmunoassay for the expression of remaining MuLV structural proteins, specifically the virus core protein p3o and the envelope glycoprotein gp69/7I. In all cases, the p3o determinant remains associated with the MSV genome. The p3o antigenic determinant of S+L-M-MSV has been demonstrated to be part of a larger 6oooo mol. wt. p6o protein precursor (Oskarsson et al. I975; Van Zaane et al. I975) . These cumulative data are strong evidence indicating that the p6o is stably linked to the transforming gene(s) of S + L-M-MSV No heterologous host S+L-cell lines had evidence for the murine leukaemia virus gp69/7I. Recent work has indicated that the gp69/7: is the virus envelope function that appears to be the primary determinant for host range, interference and neutralization properties of mammalian type C viruses (Hunsmann et al. r974) . Biological studies have demonstrated that the host range, interference and neutralization properties of the S + L-MSV rescued from heterologous host cells are determined not by the MSV genome but by the rescuing helper virus (Peebles et al. I973, I975; Hellman et al. :974; Papageorge et al. I974) . Consequently, the absence of murine gp69/7I in all of these clonally derived heterologous host S + L-cells is consistent with the biological data and both are very good evidence that the gp69/7I gene has been deleted in the formation of this MSV genome. The virus polymerase gene has also been deleted in S + L-M-MSV (Peebles et aL I975, I976a) . The deletion of both of these functions during the formation of the sarcoma virus genome would indicate that these genes may be closely linked as previously suggested (Peebles et al. I975) . Consequently, it appears that the parental replicating Moloney leukaemia virus undergoes both deletion in the polymerase and gp69/71 genes and recombines with transforming sequences to become a replication-defective but transforming virus, S+L-M-MSV (Scolnick et al. I975b; Frankel & Fischinger, 1976) .
Cumulative biological data from studies of the murine (Peebles et al. 1975, I976a; Parks et al. I976 ) and primate (Aaronson et al. 1975) transforming viruses indicate common patterns in the functions deleted and in the remaining leukaemia helper virus proteins expressed by sarcoma viruses isolated in the absence of the helper virus. These common deletion patterns are strong evidence (I) for a genome organization common to all replicating mammalian type C viruses and (2) for a common mechanism in all mammalian species for generation of transforming viruses from parental helper viruses. This mechanism must also involve recombination with new transforming sequences presumably of cell or other virus origin. The resultant deleted virus is defective in its ability to produce progeny in the absence of helper virus, but is now able to transform cells rapidly.
During the course of these studies, it was also noted that S + L-dog cells were unique in that they released large amounts of a soluble p3o antigenic determinant into their culture supernatant fluids in the absence of detectable virus particle production and under optimal conditions for cell viability. Although Bolognesi & Langlois (1975) have described the release of a soluble virus gp71 from cells, this is the first example of the in vitro release of the major structural core virus protein in a soluble form in the absence of virus particle production.
